{"mainPropery":{"diseaseId":9297,"diseaseName":"WHIM syndrome","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9297/whim-syndrome","synonyms":["Warts, Hypogammaglobulinemia, Infections, and Myelokathexis","WHIMS"],"synonyms-with-source":[{"name":"Warts, Hypogammaglobulinemia, Infections, and Myelokathexis"},{"name":"WHIMS"}],"identifiers":[{"identifierType":"OMIM","identifierId":"193670"},{"identifierType":"ORPHANET","identifierId":"51636"},{"identifierType":"UMLS","identifierId":"C0472817"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":13,"diseaseTypeName":"Immune System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":151,"resourceName":"Jeffrey Modell Foundation","abbreviation":"JMF","address1":"780 Third Ave","address2":"","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10017","country":"United States","phone":"","tty":"","tollFree":"","fax":"212-764-4180","email":"info@jmfworld.org","url":"http://www.info4pi.org/","freeText":"JMF is a global patient organization devoted to early and precise diagnosis, meaningful treatments, and ultimately, cures - through clinical and basic research, physician education, patient support, advocacy, public awareness and newborn screening."},{"resourceID":152,"resourceName":"International Patient Organization for Primary Immunodeficiencies","abbreviation":"IPOPI","address1":"Rock Bottom, Trerieve","address2":"Downderry","address3":"PL11 3LY","address4":"","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"44-01503-250-668/961","tty":"","tollFree":"","fax":"","email":"Info@ipopi.org","url":"https://ipopi.org","freeText":""},{"resourceID":161,"resourceName":"Immune Deficiency Foundation","abbreviation":"","address1":"110 West Road, Suite 300","address2":"","address3":"","address4":"","address5":"","city":"Towson","state":"MD","zip":"21204","country":"United States","phone":"","tty":"","tollFree":"1-800-296-4433","fax":"+1-410-321-9165","email":"https://www.primaryimmune.org/services/ask-idf/","url":"https://www.primaryimmune.org/","freeText":""},{"resourceID":666,"resourceName":"United States Immunodeficiency Network (USIDNET)","abbreviation":"","address1":"110 West Road, Suite 300","address2":"","address3":"","address4":"","address5":"","city":"Towson","state":"MD","zip":"21204-4803","country":"United States","phone":"443-632-2558","tty":"","tollFree":"800-296-4433 (se habla espa√±ol)","fax":"","email":"contact@usidnet.org","url":"https://www.usidnet.org","freeText":""},{"resourceID":667,"resourceName":"Canadian Immunodeficiencies Patient Organization (CIPO)","abbreviation":"","address1":"25 La Grave St ","address2":"Winnepeg, MB","address3":"","address4":"","address5":"","city":"","state":"","zip":"R3V 1J1","country":"Canada","phone":"877-262-2476 (toll-free)","tty":"","tollFree":"","fax":"866-942-7651 (toll-free)","email":"http://www.cipo.ca/#contact","url":"http://cipo.ca","freeText":""},{"resourceID":875,"resourceName":"Immune Deficiencies Foundation Australia","abbreviation":"","address1":"PO Box 969","address2":"Penrith NSW 2751","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"Australia","phone":"800-100-198","tty":"","tollFree":"","fax":"","email":"info@idfa.org.au","url":"http://www.idfa.org.au/"}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/193670' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=193670' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss WHIM syndrome. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22WHIMS%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to WHIM syndrome. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":48,"resourceId":922,"resourceName":"WHIMS - research protocol","descriptionText":"The National Institutes of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) is conducting a study titled \"A Phase I Study of Mozobil in the Treatment of Patients with WHIMS\" (Protocol no. 09-I-0200). To learn more about the study, you can contact the person listed below.<br /><br />Nana Kwatemaa, RN, MSN<br />Telephone: 301-451-7820<br />Fax: 301-451-5482<br />E-mail: <a href=\"mailto:nkwatemaa@nih.gov\">nkwatemaa@nih.gov</a>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":336,"resourceId":1154,"resourceName":"RareConnect","descriptionText":"<div style=\"margin-top: 0px; margin-bottom: 0px;\"><a href='https://www.rareconnect.org/en/community/whim-syndrome' target='_blank'>RareConnect</a> has an online community for patients&nbsp;and families with this condition so they can connect with others and share&nbsp;their experiences living with a rare disease.&nbsp;The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders).</div>","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":926,"resourceId":1860,"resourceName":"Mayo Clinic","descriptionText":"Hagan JB, Nguyen PL. <a href='http://www.mayoclinicproceedings.org/article/S0025-6196(11)61358-X/fulltext ' target='_blank'>WHIM Syndrome</a>. <em>Mayo Clin Proc</em>. September 2007;82(9):1031.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=51636' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1542,"resourceId":2170,"resourceName":"RePORTER","descriptionText":"The <a href='http://projectreporter.nih.gov/reporter.cfm' target='_blank'>Research Portfolio Online Reporting Tool (RePORT)</a> provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research.  Although these projects may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies, enter the disease name in the \"Text Search\" box.  Then click \"Submit Query\".","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1707,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"The&nbsp;<a href='http://www.ojrd.com/content/7/1/71' target='_blank'>Orphanet Journal of Rare Diseases</a> has published an article with information on this condition.&nbsp;This journal is&nbsp;affiliated with the <a href=\"http://www.orpha.net/\" target=\"_blank\">Orphanet</a>&nbsp;reference portal for information on rare diseases and orphan drugs.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:193670' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":2482,"questionText":"What is WHIM syndrome?","answerText":"<strong>WHIM syndrome&nbsp;</strong>is an acronym for a rare&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000818.htm\" target=_blank>immunodeficiency disorder</a> with each letter representing a predominant feature of the condition: (W) = <a href=\"http://www.nlm.nih.gov/medlineplus/warts.html\" target=_blank>warts</a>; (H) =&nbsp;<a href=\"http://www.merriam-webster.com/medlineplus/hypogammaglobulinemia\" target=_blank>hypogammaglobulinemia</a>;&nbsp;(I) = infections; and (M) =&nbsp;myelokathexis (retention of <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/19864.htm\" target=_blank>neutrophils</a> in the bone marrow). Symptoms usually begin in early childhood with&nbsp;recurrent bacterial infections such as respiratory infections and <a href=\"http://www.nlm.nih.gov/medlineplus/cellulitis.html\" target=_blank>cellulitis</a>. In later childhood, individuals develop widespread warts that often become persistent despite treatments that are normally effective. Warts that involve the genital area may eventually cause cancer. It is caused by&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=_blank>mutations</a> in the <a href=\"http://ghr.nlm.nih.gov/gene/CXCR4\" target=_blank><em>CXCR4</em></a> gene and is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=_blank>autosomal dominant</a> manner. Treatment may include medications that replace antibodies (intravenous immunoglobulin) or increase the number of neutrophils; vaccinations; and prophylactic antibiotics to reduce the risk of infections.[1571][4654]","dateModified":"2011-11-13T15:16:00"},"basicQuestions":[{"questionId":5643,"questionText":"How might WHIM syndrome be treated?","answerText":"Early diagnosis and&nbsp;aggressive medical management are very important for individuals with WHIM syndrome.&nbsp;Treatment of the condition currently includes G-CSF (a medication that stimulates the production of <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/19864.htm\" target=_blank>neutrophils</a>); intravenous immunoglobulins (<a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682815.html\" target=_blank>IVIG</a>) for hypogammaglobulinemia; prophylactic antibiotics to prevent infection; and aggressive surveillance for, and treatment of,&nbsp;skin and mucosal HPV-related lesions.&nbsp;The dose of&nbsp;G-CSF should be determined for each individual, and adjustments may be needed periodically. IVIG has been shown to be effective at decreasing risk of infections, and it has also been reported that the hypogammaglobulinemia may improve following treatment with G-CSF. The use of prophylactic antibiotics in individuals affected with WHIM has not been specifically studied, but the benefits have been assumed based on studies on other types of immunodeficiency disorders.&nbsp;Infections should be diagnosed and treated as soon as possible.[4655]<br><br>A new study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID)&nbsp;found that a drug called plerixafor, already approved by the Food and Drug Administration for use in patients undergoing a bone marrow transplant, may also have promise for treating people who have WHIM syndrome. Plerixafor blocks the activity of CXCR4 (which is increased in affected individuals)&nbsp;and may become a targeted therapy for WHIM syndrome.&nbsp; To read more about this ongoing study, <a href=\"http://www.clinicaltrials.gov/ct2/show/NCT00967785?term=NCT00967785&amp;rank=1\" target=_blank>click here</a>.","dateModified":"2011-11-14T15:24:00","resourceClassificationName":"Treatment","references":[{"referenceId":4655,"authors":"Kawai, Toshinaoa; Malech, Harry L","articleTitle":"WHIM syndrome: congenital immune deficiency disease","bookWebsiteJournalTitle":"Current Opinion in Hematology","date":"January 2009","volume":"16(1)","pages":"20-26"}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":32938,"abbreviatedInquiry":"My two girls have&nbsp;WHIMS and I need to know what kind of treatment they can get. We're willing to travel to seek treatment. Their WBC counts are 100-300. One has warts on her foot and the&nbsp;other has about 100 warts on each hand.","caseQuestions":[{"questionId":5643,"questionText":"How might WHIM syndrome be treated?","answerText":"Early diagnosis and&nbsp;aggressive medical management are very important for individuals with WHIM syndrome.&nbsp;Treatment of the condition currently includes G-CSF (a medication that stimulates the production of <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/19864.htm\" target=_blank>neutrophils</a>); intravenous immunoglobulins (<a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682815.html\" target=_blank>IVIG</a>) for hypogammaglobulinemia; prophylactic antibiotics to prevent infection; and aggressive surveillance for, and treatment of,&nbsp;skin and mucosal HPV-related lesions.&nbsp;The dose of&nbsp;G-CSF should be determined for each individual, and adjustments may be needed periodically. IVIG has been shown to be effective at decreasing risk of infections, and it has also been reported that the hypogammaglobulinemia may improve following treatment with G-CSF. The use of prophylactic antibiotics in individuals affected with WHIM has not been specifically studied, but the benefits have been assumed based on studies on other types of immunodeficiency disorders.&nbsp;Infections should be diagnosed and treated as soon as possible.[4655]<br><br>A new study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID)&nbsp;found that a drug called plerixafor, already approved by the Food and Drug Administration for use in patients undergoing a bone marrow transplant, may also have promise for treating people who have WHIM syndrome. Plerixafor blocks the activity of CXCR4 (which is increased in affected individuals)&nbsp;and may become a targeted therapy for WHIM syndrome.&nbsp; To read more about this ongoing study, <a href=\"http://www.clinicaltrials.gov/ct2/show/NCT00967785?term=NCT00967785&amp;rank=1\" target=_blank>click here</a>.","dateModified":"2011-11-14T15:24:00","resourceClassificationName":"Treatment","references":[{"referenceId":4655,"authors":"Kawai, Toshinaoa; Malech, Harry L","articleTitle":"WHIM syndrome: congenital immune deficiency disease","bookWebsiteJournalTitle":"Current Opinion in Hematology","date":"January 2009","volume":"16(1)","pages":"20-26"}]},{"questionId":5644,"questionText":"Where can I find information about physicians and clinics that specialize in treating individuals with WHIM syndrome?","answerText":"The National Primary Immunodeficiency Resource Center's Web site has a \"Find an Expert\" section with a listing of Referral Physicians across the world to help patients, family and friends locate a physician that is familiar with Primary Immunodeficiency (PI), and has a large PI patient base. <a href=\"http://www.info4pi.org/expertlocator/index.cfm?section=expertlocator&amp;TrkId=25&amp;CFID=211170&amp;CFTOKEN=10666831\" target=_blank>Click here</a> to search the listing.<br><br>The Immune Deficiency Foundation (IDF) maintains a database to help patients, family and friends locate a physician and their Web site has a \"Locate a Physician\" section. <a href=\"http://primaryimmune.org/patients-and-families/locate-a-physician\" target=_blank>Click here</a> to access this section.<br><br>","dateModified":"2011-11-14T14:19:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":13261,"phenoTypeName":"Abnormality of neutrophil morphology","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":1268,"phenoTypeName":"Bone marrow hypercellularity","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15526,"phenoTypeName":"Lymphopenia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4457,"phenoTypeName":"Myelokathexis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15514,"phenoTypeName":"Neutropenia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3592,"phenoTypeName":"Decreased circulating antibody level","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10670,"phenoTypeName":"Recurrent bacterial infections","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10186,"phenoTypeName":"Recurrent pneumonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":7888,"phenoTypeName":"Recurrent upper respiratory tract infections","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":968,"phenoTypeName":"Verrucae","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8111,"phenoTypeName":"Abnormality of the small intestine","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13740,"phenoTypeName":"Bronchiectasis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1204,"phenoTypeName":"Cervix cancer","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13459,"phenoTypeName":"Limb ataxia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13842,"phenoTypeName":"Neurological speech impairment","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11325,"phenoTypeName":"Otitis media","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7728,"phenoTypeName":"Pharyngitis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4479,"phenoTypeName":"Poor fine motor coordination","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13848,"phenoTypeName":"Postural instability","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9832,"phenoTypeName":"Sinusitis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4780,"phenoTypeName":"Tetralogy of Fallot","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11832,"phenoTypeName":"Atelectasis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":147,"phenoTypeName":"Cellulitis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":1689,"phenoTypeName":"Cutaneous melanoma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":7929,"phenoTypeName":"Lymphadenitis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8738,"phenoTypeName":"Meningitis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13904,"phenoTypeName":"Parotitis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":1873,"phenoTypeName":"Sepsis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":9764,"phenoTypeName":"Severe periodontitis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":9309,"phenoTypeName":"Vitiligo","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6540,"phenoTypeName":"Abnormal morphology of female internal genitalia","percentRanges":"-"},{"phenoTypeId":9592,"phenoTypeName":"Abnormality of bone marrow cell morphology","percentRanges":"-"},{"phenoTypeId":6455,"phenoTypeName":"Abnormality of female external genitalia","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":3593,"phenoTypeName":"Decreased circulating IgG level","percentRanges":"-"},{"phenoTypeId":6245,"phenoTypeName":"Infantile onset","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"WHIM_syndrome"}